Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
about
Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum ComplexesConcordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatinPhysical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expressionHexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanismThe role of BH3-mimetic drugs in the treatment of pediatric hepatoblastomaProtein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseFine tuning chemotherapy to match BRCA1 statusMicroarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinomaTandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeuticsDownstream targets of Lmo4 are modulated by cisplatin in the inner ear of Wistar ratsChemotherapeutic Drugs Interfere with Gene Delivery Mediated by Chitosan-Graft-Poly(ethylenimine)Human germ cell tumours: expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin.Photoaffinity labeling reveals nuclear proteins that uniquely recognize cisplatin-DNA interstrand cross-linksExpression proteomics study to determine metallodrug targets and optimal drug combinations.Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cellsRapid characterization of cross-links, mono-adducts, and non-covalent binding of psoralens to deoxyoligonucleotides by LC-UV/ESI-MS and IRMPD mass spectrometryA general genetic approach in Escherichia coli for determining the mechanism(s) of action of tumoricidal agents: application to DMP 840, a tumoricidal agent.Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutantsCellular responses to Cisplatin-induced DNA damage.Endocytic recycling compartments altered in cisplatin-resistant cancer cells.Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancerCopper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo.Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.Ent-11α-Hydroxy-15-oxo-kaur-16-en-19-oic-acid Inhibits Growth of Human Lung Cancer A549 Cells by Arresting Cell Cycle and Triggering Apoptosis.Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.Rapid changes of nucleotide excision repair gene expression following UV-irradiation and cisplatin treatment of Dictyostelium discoideum.Anticancer effects of crocetin in human esophageal squamous cell carcinoma KYSE-150 cells.The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YASynthesis and anti-cancer activities of a water soluble gold(III) porphyrin.Rapid gene-specific repair of cisplatin lesions at the human DUG/DHFR locus comprising the divergent upstream gene and dihydrofolate reductase gene during early G1 phase of the cell cycle assayed by using the exonucleolytic activity of T4 DNA polymeCell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.Mouse mammary tumor virus suppresses apoptosis of mammary epithelial cells through ITAM-mediated signaling.Telomere loss in cells treated with cisplatinDistinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
P2860
Q24289008-3BC58C97-BF67-4A5E-BC68-1301B2D04E8EQ24306623-DC43EEAC-C593-4344-8D02-D59101136795Q24529877-E90B99B5-460C-4C8C-A2B7-364931576BF8Q24634709-F4FD1F33-70F0-4040-85D3-595FEA13155BQ26827928-EDC9D4AC-22A5-4127-8F4A-7084FC9252C4Q27671027-7B148073-5C99-4F70-92B3-C1BDF5933CF7Q27694529-481E9122-8664-44C0-A9E4-F4F6D89CD222Q28116304-3D77F622-C3D7-41E0-B0B5-F9ED9B00B2BEQ28486298-5D264765-61BA-4A2D-A346-D72A77CA6F4AQ28542704-70FACF32-35C7-4071-B724-590C479D3183Q28547144-22A6F993-F9A6-49BF-BE16-E3858BE3363FQ30304276-57BCB3AF-188C-4D34-AAE6-A9EF644FF3F8Q33429678-2F48AE0E-804A-43D0-AC80-37E585E82006Q33685955-874CBC7C-6F6A-4B1E-AD21-C6593E668016Q33722983-A66DBAEA-6ED8-4BD2-B287-1EC40BAF5A71Q33822719-3D685883-8D40-49C7-8931-113A8F80F695Q33862921-3088B328-8B1C-4D54-8D16-AC4C1878C500Q33893171-C1616A2D-238B-4287-91DA-697E297B75BBQ33932101-372D11B8-32F5-4A49-8996-06C3C42939C3Q33940540-AF8C7C93-7522-406F-A34E-B95C8CD28BD1Q34088322-74B15014-CFF0-4A86-8758-F20FD6BD1E9DQ34089685-4A389019-AFAA-48E1-8A97-899060AD5FF4Q34406800-87176431-D5B8-438A-A11B-B6B67212CDB4Q34433775-20518A4B-1339-4908-B2BF-EDFABDF6C9E4Q34458507-3743E164-63E5-4204-B834-5CA73EF2A54AQ34517743-4DC76C0A-6E8E-4607-9EC2-A5B715BE97EDQ34565952-9CF81F49-65DB-4983-BB25-8E6FEB004878Q34625095-D39CA026-8E40-4228-91FD-ADB6F00BD983Q34671374-2FC7720F-EC16-4B02-AA43-C094B49C844FQ35042245-DC5CD0D0-4E03-476D-8D72-F41A21AAD130Q35050634-5AB38E53-F120-4AEA-985B-1560801AD536Q35176008-34EA0434-AF67-4490-A99D-494B71F2EC30Q35530076-AD7C4EC2-D6A5-4DEA-8E84-FC2C751EB448Q35888670-0F578F08-8BE1-4359-93F0-80D223B5C1EAQ36136247-6B4E9423-134A-47DC-B9A2-05086E6A9C2EQ36370912-EDD8312D-6EA9-4D40-896C-FCCF1BD83AEEQ36405766-4A559CF0-7DAA-4A04-ADF1-95DB4E468E82Q36414488-F7A5C620-53AB-4B28-84A4-E1CAD5C627FAQ36466914-A89F403E-9671-49C0-A303-8C69A691EB6EQ36521792-1B768A76-39AF-4D51-A2CA-B930C918577A
P2860
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
@en
type
label
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
@en
prefLabel
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
@en
P1476
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
@en
P2093
P304
P407
P577
1994-01-01T00:00:00Z